 | Brokerages Expect Cellectar Biosciences Inc (NASDAQ:CLRB) to Post -$0.36 EPS
www.americanbankingnews.com - February 12 at 2:20 AM |
| Cellectar Biosciences Inc (NASDAQ:CLRB) Sees Large Growth in Short Interest
www.americanbankingnews.com - February 11 at 9:51 PM |
| Cellectar Biosciences Inc (NASDAQ:CLRB) Sees Significant Decline in Short Interest
www.americanbankingnews.com - January 26 at 10:16 PM |
 | Should You Be Concerned About Cellectar Biosciences, Inc.'s (NASDAQ:CLRB) Historical Volatility?
finance.yahoo.com - January 17 at 9:53 AM |
 | Cellectar Biosciences (CLRB) Presents At Biotech Showcase 2020 - Slideshow
seekingalpha.com - January 14 at 10:08 PM |
| Cellectar Biosciences to Host a CLR 131 Clinical Data Call with Its Phase 2 Lead Investigator on February 19, 2020
finance.yahoo.com - January 9 at 2:28 PM |
| Cellectar Appoints Dr. Igor Grachev as Chief Medical Officer
finance.yahoo.com - January 7 at 5:53 PM |
| Cellectar Bio up 11% premarket on Orphan Drug tag for CLR 131 in LPL
seekingalpha.com - January 6 at 4:31 PM |
| Cellectar Receives Orphan Drug Designation for CLR 131 in Lymphoplasmacytic Lymphoma (LPL)
finance.yahoo.com - January 6 at 4:31 PM |
| Cellectar Biosciences to Present at Biotech Showcase 2020
finance.yahoo.com - December 19 at 12:23 PM |
 | BRIEF-Cellectar Announces Data From 20 Patients Receiving Single 25mCi/M2 Bolus Dose Of CLR 131 In Phase 2 CLOVER-1 Study
www.msn.com - December 16 at 7:05 PM |
| Cellectar Announces Data From 20 Patients Receiving a Single 25mCi/M2 Bolus Dose of CLR 131 in the Phase 2 CLOVER-1 Study
finance.yahoo.com - December 16 at 9:04 AM |
| Cellectar Presents Poster at the American Association for Cancer Research (AACR) San Antonio Breast Cancer Symposium
finance.yahoo.com - December 13 at 12:25 PM |
| Fractionated Dosing of CLR 131 in Patients with Relapsed or Refractory Multiple Myeloma Presented at the 61st Annual American Society of Hematology Conference
finance.yahoo.com - December 9 at 12:38 PM |
| Cellectar Announces Oral Presentation at the 61st Annual American Society of Hematology Conference
finance.yahoo.com - December 2 at 9:12 AM |
| Cellectar Biosciences EPS misses by $0.04
seekingalpha.com - November 12 at 9:51 AM |
| Cellectar Reports Third Quarter 2019 Financial Results and Provides a Corporate Update
finance.yahoo.com - November 12 at 9:51 AM |
| Cellectar Presents a New Phospholipid Drug Conjugate (PDC) at the 2019 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference
finance.yahoo.com - October 30 at 12:21 PM |
| Is Cellectar Biosciences (NASDAQ:CLRB) In A Good Position To Invest In Growth?
finance.yahoo.com - October 19 at 11:39 AM |
| Cellectar Announces Poster at the 2019 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference in Boston
finance.yahoo.com - October 17 at 9:18 AM |
| Cellectar Presents Poster at the Cancer Research UK-AACR Joint Conference on Engineering and Physical Sciences in Oncology
finance.yahoo.com - October 15 at 9:57 AM |
| Cellectar Announces Presentation at the Cancer Research UK-AACR Joint Conference on Engineering and Physical Sciences in Oncology
finance.yahoo.com - October 8 at 12:36 PM |
| Cellectar Presents Data from DLBCL Cohort of its Phase 2 CLOVER-1 Study at the European Society for Medical Oncology (ESMO) Congress
finance.yahoo.com - September 30 at 3:56 PM |
| Cellectar Receives Orphan Drug Designation from the European Commission for CLR 131 in Multiple Myeloma
finance.yahoo.com - September 24 at 8:28 AM |
| Cellectar Biosciences to Present at the Ladenburg Thalmann 2019 Healthcare Conference
finance.yahoo.com - September 19 at 8:59 AM |
| Cellectar Presents Data from Cohort 6 of its CLR 131 Phase 1 Study in Patients with Relapsed or Refractory Multiple Myeloma
finance.yahoo.com - September 16 at 9:27 AM |
| Cellectar Announces Oral Presentation at the European Society for Medical Oncology (ESMO) Congress 2019
finance.yahoo.com - September 10 at 9:08 AM |
| Cellectar Announces Late-Breaker Poster Presentation at the 17th International Myeloma Workshop
finance.yahoo.com - September 4 at 11:50 AM |
| Can We See Significant Institutional Ownership On The Cellectar Biosciences, Inc. (NASDAQ:CLRB) Share Register?
finance.yahoo.com - August 20 at 6:38 PM |
| Cellectar names Dov Elefant as CFO
seekingalpha.com - August 15 at 6:02 PM |
| Cellectar Appoints Dov Elefant as Chief Financial Officer
finance.yahoo.com - August 15 at 6:02 PM |
| CLR 131 Advances to Second Malignant Brain Tumor Cohort of Ongoing Pediatric Phase 1 Study
finance.yahoo.com - August 14 at 8:39 AM |
| Cellectar Reports Second Quarter 2019 Financial Results and Provides a Corporate Update
finance.yahoo.com - August 12 at 8:44 AM |
| Cellectar's CRL 131 Fast Track'd for DLBCL; shares up 6% premarket
seekingalpha.com - July 9 at 9:43 AM |
| Cellectar Receives FDA Fast Track Designation for CLR 131 in Diffuse Large B-Cell Lymphoma
finance.yahoo.com - July 9 at 9:43 AM |
| Cellectar up 8% on continued advancement of CLR 131
seekingalpha.com - May 21 at 11:32 AM |
| Cellectar Expands Third Cohort of its Phase 2 CLOVER-1 Study of CLR 131
finance.yahoo.com - May 21 at 11:32 AM |
| Cellectar Biosciences Announces Closing of $10.0 Million Financing
finance.yahoo.com - May 20 at 5:13 PM |
| 5 Biotech Stocks to Watch in the Second Half of 2019
finance.yahoo.com - May 20 at 12:32 PM |
| Cellectar down 25% on $10M capital raise
seekingalpha.com - May 16 at 11:03 AM |
| Cellectar Biosciences Announces $10.0 Million Financing
finance.yahoo.com - May 16 at 11:03 AM |
| Cellectar up 31% on more positive CLR 131 data
seekingalpha.com - May 15 at 6:46 PM |
| CLR 131 Achieves 50% Overall Response Rate in Cohort 6 of Ongoing Phase 1 Study in Relapsed or Refractory Multiple Myeloma
finance.yahoo.com - May 15 at 9:35 AM |
| Cellectar's CLR 131 Fast Track'd for multiple myeloma; shares up 6%
seekingalpha.com - May 13 at 6:41 PM |
| Cellectar Receives FDA Fast Track Designation for CLR 131 in Relapsed or Refractory Multiple Myeloma
finance.yahoo.com - May 13 at 9:35 AM |
| Cellectar Reports First Quarter 2019 Financial Results and Provides a Corporate Update
finance.yahoo.com - May 6 at 9:35 AM |
| Cellectar Biosciences, Inc. (NASDAQ:CLRB): Are Analysts Right About The Drop In Earnings?
finance.yahoo.com - April 29 at 5:46 PM |
 | U.S. STOCKS ON THE MOVE-Weed Stocks, Revlon, Shineco - Nasdaq
www.nasdaq.com - March 20 at 9:18 AM |
 | Cellectar Biosciences Inc.
www.barrons.com - March 19 at 6:26 PM |
| Cellectar Bio up 40% premarket on advancement of CLR 131
seekingalpha.com - March 19 at 6:26 PM |
